BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2680618)

  • 1. Validity of the Bioself 110 fertility indicator.
    Labrecque M; Drouin J; Rioux JE; Gingras S; Spieler JM
    Fertil Steril; 1989 Oct; 52(4):604-8. PubMed ID: 2680618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the BIOSELF 110 fertility indicator.
    Ismail M; Arshat H; Pulcrano J; Royston P; Spieler J
    Contraception; 1989 Jan; 39(1):53-71. PubMed ID: 2642781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the Bioself 110 electronic fertility indicator as a contraceptive aid.
    Flynn A; Pulcrano J; Royston P; Spieler J
    Contraception; 1991 Aug; 44(2):125-39. PubMed ID: 1893707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive application of the Bioself fertility indicator.
    Drouin J; Guilbert EE; Désaulniers G
    Contraception; 1994 Sep; 50(3):229-38. PubMed ID: 7805373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUE Fertility Monitor compared to ultrasound and LH peak measurements for fertile time ovulation detection.
    Freundl G; Bremme M; Frank-Herrmann P; Baur S; Godehardt E; Sottong U
    Adv Contracept; 1996 Jun; 12(2):111-21. PubMed ID: 8863906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Salivary LH as an ovulation indicator: on the value of autopalpation of the cervix uteri for the detection of fertile and infertile days of the cycle].
    Loewit K; Wolfram G; Ortlieb A; Widhalm R
    Geburtshilfe Frauenheilkd; 1987 Nov; 47(11):803-7. PubMed ID: 3692114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inaccuracy of basal body temperature charts in predicting urinary luteinizing hormone surges.
    Quagliarello J; Arny M
    Fertil Steril; 1986 Mar; 45(3):334-7. PubMed ID: 3949032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the ovulation method with the CUE ovulation predictor in determining the fertile period.
    Fehring RJ
    J Am Acad Nurse Pract; 1996 Oct; 8(10):461-6. PubMed ID: 9305046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personal hormone monitoring for contraception.
    Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
    Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated maximum failure rates of cycle monitors using daily conception probabilities in the menstrual cycle.
    Freundl G; Godehardt E; Kern PA; Frank-Herrmann P; Koubenec HJ; Gnoth Ch
    Hum Reprod; 2003 Dec; 18(12):2628-33. PubMed ID: 14645183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring techniques to predict and detect ovulation.
    Vermesh M; Kletzky OA; Davajan V; Israel R
    Fertil Steril; 1987 Feb; 47(2):259-64. PubMed ID: 3817171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements.
    Behre HM; Kuhlage J; Gassner C; Sonntag B; Schem C; Schneider HP; Nieschlag E
    Hum Reprod; 2000 Dec; 15(12):2478-82. PubMed ID: 11098014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the hormonally estimated fertile phase of the menstrual cycle.
    Fehring RJ; Schneider M
    Fertil Steril; 2008 Oct; 90(4):1232-5. PubMed ID: 18249381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of perception of ovulation day in women trying to conceive.
    Zinaman M; Johnson S; Ellis J; Ledger W
    Curr Med Res Opin; 2012 May; 28(5):749-54. PubMed ID: 22462529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized protocols for characterizing women's fertility: A data-driven approach.
    Blake KR; Dixson BJ; O'Dean SM; Denson TF
    Horm Behav; 2016 May; 81():74-83. PubMed ID: 27072982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the OvuSTICK urinary luteinizing hormone kit in normal and stimulated menstrual cycles.
    Elkind-Hirsch K; Goldzieher JW; Gibbons WE; Besch PK
    Obstet Gynecol; 1986 Mar; 67(3):450-3. PubMed ID: 3511422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the phases of the menstrual cycle.
    Fehring RJ; Schneider M; Raviele K
    J Obstet Gynecol Neonatal Nurs; 2006; 35(3):376-84. PubMed ID: 16700687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risks of the natural family planning methods].
    Zufferey MM
    Ther Umsch; 1986 May; 43(5):417-24. PubMed ID: 3726778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature.
    Regidor PA; Kaczmarczyk M; Schiweck E; Goeckenjan-Festag M; Alexander H
    Gynecol Endocrinol; 2018 Mar; 34(3):256-260. PubMed ID: 29082805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.